Patent 10583110 - Antitumoral use of cabazitaxel > Summary

US Patent

Patent Application No. US 10583110

Published on Mar 10, 2020

Application No. 15/627962

Field on Jun 20, 2017

Classification

International:

A61K 31/337

A61K 31/164;

A61K 31/56;

A61K 31/573;

A61K 45/06;

A61K 38/19;